Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Phillip Koeffler, M.D.

Cedars-Sinai Medical Center # of Grants: 3

Grants

Discovery of serum markers of lung cancer 1998 (Cycle 7) $120,300
Cancer Inno Dev & Exp Awards (IDEAS)

Lung Cancer: p53 as a Paradigm of Tumor Suppression 1992 (Cycle 1) $138,420
Cancer Research Project Awards

Lung Cancer: p53 as a Paradigm of Tumor Suppression 1992 (Cycle 1) $327,795
Cancer Research Project Awards
Publications

Cyr61 suppresses the growth of non-small cell lung cancer cells via the beta-catenin- c-myc-p53 pathway.
Periodical: Index Medicus:
Authors: Tong X, and Koeffler HP ART
Yr: Vol: Nbr: Abs: Pg:

Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.
Periodical: Journal of Biological Chemistry Index Medicus:
Authors: Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, and Koeffler HP ART
Yr: 0 Vol: Nbr: Abs: Pg:

Cyr61 suppresses the growth of non-small cell lung cancer cells via the beta-catenin- c-myc-p53 pathway.
Periodical: Index Medicus:
Authors: Tong X, and Koeffler HP ART
Yr: Vol: Nbr: Abs: Pg:

Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.
Periodical: Journal of Biological Chemistry Index Medicus:
Authors: Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, and Koeffler HP ART
Yr: 0 Vol: Nbr: Abs: Pg:

A potential transcriptional activation element in the p53 protein
Periodical: Oncogene Index Medicus:
Authors: O'Rourke RW, Miller CW, Kato GJ, et al. ART
Yr: 1990 Vol: 5 Nbr: 12 Abs: Pg: 1829-1832

p53 Mutation in Human Lung Tumors
Periodical: Cancer Research Index Medicus:
Authors: Miller CW, Simon K, Aslo A, et al ART
Yr: 1992 Vol: 52 Nbr: 7 Abs: Pg: 1695-1698

Molecular mechanisms of cancer
Periodical: Index Medicus:
Authors: Koeffler HP, McCormick F, Denny C ART
Yr: 1991 Vol: 155 Nbr: Abs: Pg: 505-514

Mutations of p53 and human papillomavirus infection occur independently in cervical carcinoma
Periodical: Cancer Index Medicus:
Authors: Paquette RL, Karmakar A, Kizaki M, Wilcynzski SP, Miller CW, Koeffler HP ART
Yr: 1993 Vol: 72 Nbr: 4 Abs: Pg: 1272-1280

Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription
Periodical: Oncogene Index Medicus:
Authors: Miller CW, Chumakov A, Said J, Chen DL, Aslo A, Koeffler HP ART
Yr: 1993 Vol: 8 Nbr: 7 Abs: Pg: 1815-1824

A potential transcriptional activation element in the p53 protein
Periodical: Oncogene Index Medicus:
Authors: O'Rourke RW, Miller CW, Kato GJ, et al. ART
Yr: 1990 Vol: 5 Nbr: 12 Abs: Pg: 1829-1832

p53 Mutation in Human Lung Tumors
Periodical: Cancer Research Index Medicus:
Authors: Miller CW, Simon K, Aslo A, et al ART
Yr: 1992 Vol: 52 Nbr: 7 Abs: Pg: 1695-1698

Molecular mechanisms of cancer
Periodical: Index Medicus:
Authors: Koeffler HP, McCormick F, Denny C ART
Yr: 1991 Vol: 155 Nbr: Abs: Pg: 505-514

Mutations of p53 and human papillomavirus infection occur independently in cervical carcinoma
Periodical: Cancer Index Medicus:
Authors: Paquette RL, Karmakar A, Kizaki M, Wilcynzski SP, Miller CW, Koeffler HP ART
Yr: 1993 Vol: 72 Nbr: 4 Abs: Pg: 1272-1280

Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription
Periodical: Oncogene Index Medicus:
Authors: Miller CW, Chumakov A, Said J, Chen DL, Aslo A, Koeffler HP ART
Yr: 1993 Vol: 8 Nbr: 7 Abs: Pg: 1815-1824